Top 5 News Stories 4/20-4/27

1. AMAG to get $30M milestone payment Mass High Tech – 4/20/12

AMAG Pharmaceuticals of Lexington has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for the approval for its intravenous iron therapy for the treatment of iron deficiency anemia in adults with chronic kidney disease. Link

2. Poll Majority Confident that Massachusetts Can Maintain Biopharma Construction Boom GEN – 4/23/12

With a combined 3.5 million plus square feet of lab and office space totaling more than $2 billion under construction across Massachusetts, GEN online readers are confident that the Bay State can sustain its biopharma construction boom. Link

3. Life Sciences Center awards $2.3M in loans Boston Herald – 4/24/12

The Massachusetts Life Sciences Center today awarded $2.3 million in loans to five early-stage life sciences companies through its Accelerator Program to support them at the most critical stages of their development cycle. Link

4. Thermalin Diabetes gets $4.5M NIH grant for next-generation insulin MedCity News – 4/25/12

Next-generation insulin developer Thermalin Diabetes has received a $4.5 million grant from the National Institutes of Health to continue development of its insulin analogs. Link

5. White House Promotes a Bioeconomy New York Times – 4/26/12

The Obama administration is expected to announce a broad plan on Thursday to foster development of the nation’s “bioeconomy,” including the use of renewable resources and biological manufacturing methods. Link